» Articles » PMID: 32271376

Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)

Abstract

Background: An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public health emergency. Data are limited on the duration and host factors related to viral shedding.

Methods: In this retrospective study, risk factors associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding were evaluated in a cohort of 113 symptomatic patients from 2 hospitals outside Wuhan.

Results: The median (interquartile range) duration of SARS-CoV-2 RNA detection was 17 (13-22) days as measured from illness onset. When comparing patients with early (<15 days) and late (≥15 days after illness onset) viral RNA clearance, prolonged SARS-CoV-2 RNA shedding was associated with male sex (P = .009), old age (P = .033), concomitant hypertension (P = .009), delayed admission to hospital after illness onset (P = .001), severe illness at admission (P = .049), invasive mechanical ventilation (P = .006), and corticosteroid treatment (P = .025). Patients with longer SARS-CoV-2 RNA shedding duration had slower recovery of body temperature (P < .001) and focal absorption on radiograph images (P < .001) than patients with early SARS-CoV-2 RNA clearance. Male sex (OR, 3.24; 95% CI, 1.31-8.02), delayed hospital admission (OR, 1.30; 95% CI, 1.10-1.54), and invasive mechanical ventilation (OR, 9.88; 95% CI, 1.11-88.02) were independent risk factors for prolonged SARS-CoV-2 RNA shedding.

Conclusions: Male sex, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. Hospital admission and general treatments should be started as soon as possible in symptomatic COVID-19 patients, especially male patients.

Citing Articles

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape.

Zhang W, Gai X, Duan Z, Yan C, Huang C, Wu C Front Med (Lausanne). 2025; 11:1478466.

PMID: 39931433 PMC: 11808361. DOI: 10.3389/fmed.2024.1478466.


Time to recovery of COVID-19 patients and its predictors: a retrospective cohort study in HUCSH, Sidama, Ethiopia.

Anteneh A, Asfaw Z BMC Public Health. 2025; 25(1):74.

PMID: 39773164 PMC: 11707994. DOI: 10.1186/s12889-024-21229-7.


Defining the Differential Corticosteroid Response Basis from Multiple Omics Approaches.

Ramirez-Falcon M, Suarez-Pajes E, Flores C Int J Mol Sci. 2025; 25(24.

PMID: 39769372 PMC: 11679800. DOI: 10.3390/ijms252413611.


Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding.

Zhang Y, Li Q, Duan H, Tan L, Cao Y, Chen J J Transl Med. 2024; 22(1):1054.

PMID: 39578848 PMC: 11583424. DOI: 10.1186/s12967-024-05872-7.


Role of Carcinoembryonic Antigen in Severity Assessment and Mortality Prediction in COVID-19 Patients.

Anjan M, Ahmed Q, Masum A, Sami C, Matin M, Islam M Cureus. 2024; 16(9):e69894.

PMID: 39439636 PMC: 11494406. DOI: 10.7759/cureus.69894.